Ocera Therapeutics, Inc. — Form D

Ocera Therapeutics, Inc. of Palo Alto, CA, a company, filed a Form D exempt-offering notice with the SEC on 2013-07-24. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (27)

Showing 25 of 27 people.

NameRoleLocation
Jean-Paul F CastaigneDirectorSan Diego, CA
Lars F EkmanDirectorSan Diego, CA
Nina S KjellsonDirectorPalo Alto, CA
Linda S GraisExecutive OfficerPalo Alto, CA
Dana S McGowanExecutive OfficerSan Diego, CA
Franck S RousseauExecutive OfficerPalo Alto, CA
Eckard F WeberDirectorPalo Alto, CA
Nina L KjellsonDirectorPalo Alto, CA
Pratik F ShahDirectorPalo Alto, CA
Franck S RousseauDirectorPalo Alto, CA
Jeryl L HillemanExecutive OfficerPalo Alto, CA
Jean-Paul G CastaigneDirectorPalo Alto, CA
David S MooreExecutive OfficerPalo Alto, CA
Lars G EkmanDirectorPalo Alto, CA
Linda S GraisDirectorPalo Alto, CA
Anne M VanLentDirectorPalo Alto, CA
Anne M VanLentExecutive OfficerPalo Alto, CA
Michael F PowellDirectorPalo Alto, CA
Alex D ZissonDirectorStamford, CT
DAVID J DRUTZDirectorMONTREAL, A8
Brenda D GavinDirectorPhiladelphia, PA
Donald F CorcoranDirectorDurham, NC
Aaron F DavidsonDirectorDurham, NC
Richard I EisenstadtExecutive OfficerDurham, NC
Vipin K GargDirectorDurham, NC

Other filings by this issuer (5)

FiledFormOfferingSold
2013-11-21D$28.0M$28.0M
2013-07-16D$20.0M
2013-07-16D
2013-07-16D/A
2010-06-24D$3.0M$2.0M

More